Update and progress of the response-to-therapy assessment system in differentiated thyroid cancer

VernacularTitle:有关分化型甲状腺癌治疗反应评估体系的解读
Author: Min HOU ; Yansong LIN
Keywords: Thyroid neoplasms; Treatment outcome; Practice guideline
From: Chinese Journal of Nuclear Medicine and Molecular Imaging 2017;37(7):420-425
CountryChina
Language:Chinese
Abstract: Recent research has gained much depth and details on the response-to-therapy assessment system (RTAS) of DTC. The concept of RTAS was first proposed in the 2015 ATA guidelines, mainly advocating dynamic and ongoing assessment of a disease process after primary therapy is completed. This recommendation is to compensate for the deficiency of a static, single-parametric evaluation system that is conventionally pathology-dominated. The concept of risk-adaptive management has been adopted in individual decision-making processes, so as to tailor treatment plans accordingly with an understanding that therapies (e.g. surgery, etc.) should also be involved as a continuum of risk assessment. The RTAS according to the new guidelines has been clearly highlighted worldwide. This review aims to outline the progress and latest update of RTAS on DTC.